Usefulness of dexmedetomidine for endoscopic submucosal dissection in colon

Usefulness of dexmedetomidine for endoscopic submucosal dissection in colon - Usefulness of dexmedetomidine for endoscopic submucosal dissection in colon

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021769

Enrollment

Registered

2016-04-07

Start date

2016-04-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal tumor

Interventions

dexmedetomidine placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients for whom ESD in colon will be performed 2)Patients who have provided written informed consent for participation in this study

Exclusion criteria

Exclusion criteria: Patients judged by the principal investigator or subinvestigator to be unsuitable for participation for any other reason (to ensure the safe conduct of this study)

Design outcomes

Primary

Measure	Time frame
Satisfaction in patient	—

Secondary

Measure	Time frame
Patients' pain level (VAS) Endoscopists' satisfaction (VAS) Objective patients' pain level viewed from endoscopists (VAS) Movement (VAS) Difficulty (VAS) Rate of response Rate of en bloc Rate of R0 resection Resection time Resected section diameter Total amount of analgesic Rate of side effects Rate of complications	—

Countries

Japan

Contacts

Public ContactHideaki Kinugasa

Hiroshima City Hiroshima Citizens Hospital Internal medicine

gyacy14@gmail.com082-221-2291

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026